Jinqi Biological Group

Jinyu Bio-technology, frequently referred to as Jinqi Biological Group in relation to its flagship industrial operations, is a leading Chinese biotechnology company specializing in animal health and veterinary vaccines. The company is a dominant player in the production of vaccines for Foot-and-Mouth Disease (FMD), being the first in China to implement large-scale suspension culture and advanced antigen purification technologies. Its primary manufacturing hub, the Jinqi Bio-pharmaceutical Industrial Park in Hohhot, is a state-of-the-art facility that integrates smart manufacturing with high-containment biosafety standards. Jinyu Bio-technology's extensive product portfolio includes vaccines for swine, cattle, sheep, and poultry, as well as diagnostic reagents and pet health products. Publicly traded on the Shanghai Stock Exchange, the company maintains strong R&D collaborations with national research institutes to combat emerging livestock diseases.